Effect of pre-analytic variables on the reproducibility of qPCR relative telomere length measurement

PLoS One. 2017 Sep 8;12(9):e0184098. doi: 10.1371/journal.pone.0184098. eCollection 2017.

Abstract

Telomeres, long nucleotide repeats and a protein complex at chromosome ends, shorten with each cell division and are susceptible to oxidative damage. Quantitative PCR (qPCR) is a widely-used technique to measure relative telomere length (RTL) in DNA samples but is challenging to optimize and significant lab-to-lab variability has been reported. In this study, we evaluated factors that may contribute to qPCR RTL measurement variability including DNA extraction methods, methods used for removing potential residual PCR inhibitors, sample storage conditions, and sample location in the PCR plate. Our results show that the DNA extraction and purification techniques, as well as sample storage conditions introduce significant variability in qPCR RTL results. We did not find significant differences in results based on sample location in the PCR plate or qPCR instrument used. These data suggest that lack of reproducibility in published association studies of RTL could be, in part, due to methodological inconsistencies. This study illustrates the importance of uniform sample handling, from DNA extraction through data generation and analysis, in using qPCR to determine RTL.

MeSH terms

  • DNA / genetics
  • DNA / isolation & purification
  • Humans
  • Real-Time Polymerase Chain Reaction* / methods
  • Real-Time Polymerase Chain Reaction* / standards
  • Reproducibility of Results
  • Specimen Handling / methods
  • Specimen Handling / standards
  • Telomere / genetics*
  • Telomere Homeostasis / genetics*

Substances

  • DNA

Grants and funding

This study was supported by the intramural research program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute. Authors CLD, BH, KT, AAH, and MY are employees of Leidos Biomedical Research, Inc. a subsidiary of Leidos dedicated to a single contract to the Frederick National Laboratory for Cancer Research, which is sponsored by the National Cancer Institute (https://www.leidos.com/about/subsidiaries/leidos-biomedical-research). Leidos Biomedical Research, Inc., did not play a role in study design, data collection or analysis, or preparation of the manuscript.